Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma

Rituximab maintenance (RM) after autologous stem cell transplantation (ASCT) is standard-of-care for young patients with mantle cell lymphoma (MCL). RM may enhance post-transplantation immune depression and risk of infections. We compared infection incidence and immune consequences of RM versus obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouard, Louise, Tessoulin, Benoit, Thieblemont, Catherine, Bouabdallah, Kamal, Gastinne, Thomas, Oberic, Lucie, Carras, Sylvain, Delette, Caroline, Casasnovas, Olivier, Dartigeas, Caroline, Cacheux, Victoria, Masse, Sibylle, Hermine, Olivier, Le Gouill, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Non-Hodgkin Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425317/
https://www.ncbi.nlm.nih.gov/pubmed/35172560
http://dx.doi.org/10.3324/haematol.2021.279561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425317/
https://www.ncbi.nlm.nih.gov/pubmed/35172560
http://dx.doi.org/10.3324/haematol.2021.279561

Ejemplares similares